Target intelligence / Profile preview

Ureaplasma parvum DNA (U. parvum DNA)

Target
U. parvum DNA
Molecular classification
Nucleic acid, Bacterial genome
01

Overview

Ureaplasma parvum DNA represents the genetic material of a wall-less bacterium that is a common member of the human urogenital microbiota [StatPearls, 2023]. This circular, double-stranded DNA molecule encodes the essential biological instructions for the organism, including the urease enzyme complex which is critical for its survival and energy production through urea hydrolysis [PubMed, 2020]. While often existing as a commensal, the presence and replication of U. parvum DNA are associated with several inflammatory conditions, such as non-gonococcal urethritis, cervicitis, and adverse pregnancy outcomes like preterm labor [NIH, 2022]. The DNA itself serves as the primary target for diagnostic molecular assays, such as quantitative PCR, which identify specific sequences like the 16S rRNA or urease genes to confirm infection [Journal of Clinical Microbiology, 2018]. Pharmacologically, the replication and integrity of this DNA are disrupted by fluoroquinolone antibiotics, which trap DNA gyrase and topoisomerase IV on the DNA to induce lethal double-strand breaks [Nature Reviews Microbiology, 2017]. Furthermore, the DNA acts as the template for all bacterial proteins, making its expression an indirect target for macrolides and tetracyclines that inhibit the bacterial ribosome [StatPearls, 2023].

Other names
Ureaplasma parvum genomeU. parvum chromosomeUreaplasma parvum genomic DNA
02

Mechanism of action

Inhibition of DNA replication and transcription through the stabilization of DNA-enzyme cleavage complexes (e.g., DNA gyrase and topoisomerase IV) or through the inhibition of protein synthesis machinery required for DNA maintenance.

03

Biological functions

Genetic information storageTemplate for DNA replicationTemplate for RNA transcription
04

Disease associations

InfectionNon-gonococcal urethritisPelvic inflammatory diseasePreterm birthNeonatal respiratory distress syndromeChorioamnionitis
05

Safety considerations

Development of antimicrobial resistance (macrolide and tetracycline resistance)Disruption of the host commensal microbiomePotential for horizontal gene transfer of resistance genes
06

Interacting drugs

Levofloxacin

4 more in the full profile.

07

Biomarkers

16S ribosomal RNA (16S rRNA) geneUrease gene complex (ureA, ureB, ureC, ureD)Multiple banded antigen (MBA) gene

Beyond the preview

Go deeper on Ureaplasma parvum DNA (U. parvum DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ureaplasma parvum DNA (U. parvum DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call